Sinusoidal endothelial dysfunction precedes inflammation and fibrosis in a model of NAFLD. - Wikidata - thesis-toulmin - TriplyDB

Sinusoidal endothelial dysfunction precedes inflammation and fibrosis in a model of NAFLD.

Sinusoidal endothelial dysfunction precedes inflammation and fibrosis in a model of NAFLD.

http://www.wikidata.org/entity/Q34234946

about

Strategies to rescue steatotic livers before transplantation in clinical and experimental studies CEUS and Fibroscan in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis Hepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease.Reduced hepatic eNOS phosphorylation is associated with NAFLD and type 2 diabetes progression and is prevented by daily exercise in hyperphagic OLETF rats Longitudinal assessment of high blood pressure in children with nonalcoholic fatty liver disease M1 polarization bias and subsequent nonalcoholic steatohepatitis progression is attenuated by nitric oxide donor DETA NONOate via inhibition of CYP2E1-induced oxidative stress in obese mice.Upregulation of miR21 and repression of Grhl3 by leptin mediates sinusoidal endothelial injury in experimental nonalcoholic steatohepatitis.P2X7 receptor as a key player in oxidative stress-driven cell fate in nonalcoholic steatohepatitis.Nonalcoholic Steatohepatitis: A Search for Factual Animal Models.The Relationship of Fat Distribution and Insulin Resistance with Lumbar Spine Bone Mass in Women NADPH Oxidase-Derived Peroxynitrite Drives Inflammation in Mice and Human Nonalcoholic Steatohepatitis via TLR4-Lipid Raft Recruitment Peripheral and Hepatic Vein Cytokine Levels in Correlation with Non-Alcoholic Fatty Liver Disease (NAFLD)-Related Metabolic, Histological, and Haemodynamic Features Nonalcoholic fatty liver disease and vascular function: cross-sectional analysis in the Framingham heart study.Contribution of Cyclooxygenase End Products and Oxidative Stress to Intrahepatic Endothelial Dysfunction in Early Non-Alcoholic Fatty Liver Disease.Free Fatty Acids Differentially Downregulate Chemokines in Liver Sinusoidal Endothelial Cells: Insights into Non-Alcoholic Fatty Liver Disease."Non alcoholic fatty liver disease and eNOS dysfunction in humans"Liver X receptor α is essential for the capillarization of liver sinusoidal endothelial cells in liver injury Sparstolonin B attenuates early liver inflammation in experimental NASH by modulating TLR4 trafficking in lipid rafts via NADPH oxidase activation Correlations of Hepatic Hemodynamics, Liver Function, and Fibrosis Markers in Nonalcoholic Fatty Liver Disease: Comparison with Chronic Hepatitis Related to Hepatitis C Virus Management and diagnosis of fatty liver disease.A Combination of Leucine, Metformin, and Sildenafil Treats Nonalcoholic Fatty Liver Disease and Steatohepatitis in Mice.Endothelial Dysfunction and Mechanobiology in Pathological Cutaneous Scarring: Lessons Learned from Soft Tissue Fibrosis.Non-alcoholic fatty liver disease, to struggle with the strangle: Oxygen availability in fatty livers.Pivotal role of liver sinusoidal endothelial cells in NAFLD/NASH progression.A Nitric Oxide-Donating Statin Decreases Portal Pressure with a Better Toxicity Profile than Conventional Statins in Cirrhotic Rats.A computer model simulating human glucose absorption and metabolism in health and metabolic disease states.Effects of simvastatin administration on rodents with lipopolysaccharide-induced liver microvascular dysfunction.Intrahepatic vascular changes in non-alcoholic fatty liver disease: Potential role of insulin-resistance and endothelial dysfunction.The NOX1 isoform of NADPH oxidase is involved in dysfunction of liver sinusoids in nonalcoholic fatty liver disease.Severe steatosis induces portal hypertension by systemic arterial hyporeactivity and hepatic vasoconstrictor hyperreactivity in rats.Microcirculatory disturbances and cellular changes during progression of hepatic steatosis to liver tumors.TRPV4 activation of endothelial nitric oxide synthase resists nonalcoholic fatty liver disease by blocking CYP2E1-mediated redox toxicity.Assessment of Nonalcoholic Fatty Liver Disease in Rats Using Quantitative Dynamic Contrast-Enhanced MRI.Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease.Association between abdominal adiposity and subclinical measures of left-ventricular remodeling in diabetics, prediabetics and normal controls without history of cardiovascular disease as measured by magnetic resonance imaging: results from the KORA Managing portal hypertension in patients with liver cirrhosis.Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease.Effect of low molecular grape seed proanthocyanidins on blood pressure and lipid homeostasis in cafeteria diet-fed rats

P2860

Q27003912-917461DC-B342-41D5-9E76-315ABD849825 Q30434253-F2232353-3AA6-4A18-A6DC-E1EAA3CDBDF1 Q33811776-83162886-83D1-437F-91BA-6ACCDBE6679A Q33900501-F253E077-1389-49EF-95FB-20862A5AE028 Q34566072-DFDE9069-14EB-46B0-8F7E-BFC98F716B69 Q34785593-6FB02AF9-EB7E-4B6D-96A4-CEDF5A4B4F2D Q35057717-012E0C46-2FE4-4FC2-B35F-30B2180A21E1 Q35178036-0E9CBBC3-A952-44EB-908F-DE4A29C97264 Q35612535-B62463F6-7CD1-4811-9047-EAFB990D4AD4 Q35661534-D7FC64D3-F6F4-4BFE-8A14-C795DCEF8C25 Q35790133-E3B1DB3E-11BC-4BF0-A8A6-FD0FB504093A Q35850234-2C03E2B7-B21F-47B6-812C-039CBD69FE66 Q35903742-706D5489-35CD-4E64-BEC8-F7A8872D30AF Q36030209-06054DE0-2436-4FE4-9501-73DAAC8C98CC Q36084783-C0B123FB-57DE-44A1-8B19-F0E731034DDF Q36298719-A784CDAE-2A58-4929-8CF2-8CC0757AF031 Q36591996-BDCEFCB4-6CF0-4CD0-B83B-4B1D9CDE58C9 Q36775835-12F1E1CD-9D10-4DC1-A44E-B94BCD0F326A Q37286603-B72ED102-F5D4-4C91-A156-2E52E91D04BF Q38365276-845D0BC1-6CE2-4819-8D5A-DBB0480703AB Q39044686-B7BE7F33-892C-4960-A0AB-DC156500E529 Q39238174-65CBE58E-39DE-4C4D-91A8-4144BAF3C059 Q39408396-73797FE7-6B7B-4B15-A6B8-2117D5F90F92 Q40691956-BD2002C9-0607-4D02-89C2-AD77D031D0F6 Q41848559-70169E64-A397-4933-BC93-90772507E696 Q42707414-2E24794B-0DB3-49E9-90A4-A2943077A665 Q44743116-452A4C80-1E83-4205-90F4-17A2E1BFC1C5 Q46517321-C1783A8C-795B-4578-9FC9-6ABD4EB35D7B Q47258601-226A722A-42BB-492D-BC01-AD7E1BF40CD8 Q48043433-86BD89D7-5FA4-40A4-9825-73431DF1448A Q50077361-6C86103F-CE07-45C2-8019-CAEFA947E633 Q51288882-E39DB43A-B853-4134-AC77-550261F89EF7 Q53032280-3F0ADE2A-7096-410D-AD1F-F31665660C83 Q54967305-D645F8FB-E594-4887-8540-FD8D28130A84 Q55266890-8C69B465-BD88-4458-B938-A12F56F40DF5 Q55278061-8F3B2E22-F55B-4539-A4F6-7B3426C70D4D Q55501328-5A3131F0-AAFF-405A-A016-BFEB763A8FDA Q58817344-132B8CD0-7FAD-49AC-83EC-E6361D8B14BC

P2860

Sinusoidal endothelial dysfunction precedes inflammation and fibrosis in a model of NAFLD.

http://www.wikidata.org/entity/Q34234946

description

2012 nî lūn-bûn

@nan

2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Sinusoidal endothelial dysfunc ...... fibrosis in a model of NAFLD.

@ast

Sinusoidal endothelial dysfunc ...... fibrosis in a model of NAFLD.

@en

Sinusoidal endothelial dysfunc ...... fibrosis in a model of NAFLD.

@nl

type

label

Sinusoidal endothelial dysfunc ...... fibrosis in a model of NAFLD.

@ast

Sinusoidal endothelial dysfunc ...... fibrosis in a model of NAFLD.

@en

Sinusoidal endothelial dysfunc ...... fibrosis in a model of NAFLD.

@nl

prefLabel

Sinusoidal endothelial dysfunc ...... fibrosis in a model of NAFLD.

@ast

Sinusoidal endothelial dysfunc ...... fibrosis in a model of NAFLD.

@en

Sinusoidal endothelial dysfunc ...... fibrosis in a model of NAFLD.

@nl

P1433

Q34234946-96BDC403-6BE3-4E1F-ACB0-DBE1104797AB

P1476

Q34234946-A972F9C6-06B4-4634-B172-A9C12AAE0757

P2093

Q34234946-00777140-95FB-4C86-8A8A-412703F5BBFD

Q34234946-0230E1DD-AF0D-4998-8F9F-6A6050ED0712

Q34234946-23153954-8A47-49FF-B6B7-898357FDB463

Q34234946-4ADE6B3A-543F-4FCD-8611-B48F339988BE

Q34234946-642D290F-3A22-4868-AD28-7CE92612D57F

P2860

Q34234946-03E51E90-331B-4972-9992-7B021650EEE8

Q34234946-08AC10B0-A641-4A87-9077-05D1894261C5

Q34234946-0E36CF8D-9A08-4C58-B2C6-98B85F8F0D16

Q34234946-108F0F30-D0EC-4D27-A649-6CB695BD7BE7

Q34234946-1AF924E7-185F-4516-B1A3-7F4841AD134A

Q34234946-1E8B77FC-34EC-4E4A-B1C0-28BB32E5DDFB

Q34234946-28A4EAF8-BFF3-4BD1-8E0F-DB184222CBDB

Q34234946-30AA6E72-0E8D-4C64-9392-56937B9E5F8B

Q34234946-321940DA-55C0-4E35-8808-7F16E658170E

Q34234946-324DD0D4-222A-4649-B972-6758B88B79F1

P304

Q34234946-3A18981B-556B-46A5-BEBD-50C707A040AC

P31

Q34234946-75BFB7EA-218D-4678-960D-6B4FE7586A47

P356

Q34234946-39B6E0F4-D38A-4B2F-90CC-49CC58F73985

P407

Q34234946-A139A850-89D9-4E32-BFC8-3460005EDC6C

P433

Q34234946-4A9BFF88-DCCE-4E52-9E56-A8A6B4DC390D

P478

Q34234946-BD0B1A0C-F053-4E80-B670-E57D4CE369D9

P50

Q34234946-13E3B701-2F8F-4404-88AA-2428D5F7D7FD

Q34234946-15D5FFC9-C8FD-49B0-8B0D-0AD158661B22

Q34234946-3C6B4B77-84D2-41FA-B121-FA03FFDC614D

P577

Q34234946-B2927EF4-ACF7-459B-BA6A-76DCA0B2D9C5

P5875

Q34234946-42B8392F-272D-489E-B5CA-46359FF94B72

P698

Q34234946-ECC75B3A-706C-4470-9860-707FB28D03EC

P921

Q34234946-3F3BF816-75D1-4123-9683-8C928A3A83DC

P932

Q34234946-6515A756-1E5D-476F-B661-8755E647C004

P356

JOURNAL.PONE.0032785

P1433

P1476

Sinusoidal endothelial dysfunction precedes inflammation and fibrosis in a model of NAFLD

@en

P2093

Aina Rodríguez-Vilarrupla

http://www.w3.org/2001/XMLSchema#string

Héctor García-Calderó

http://www.w3.org/2001/XMLSchema#string

Jaime Bosch

http://www.w3.org/2001/XMLSchema#string

Juan G Abraldes

http://www.w3.org/2001/XMLSchema#string

Marcos Pasarín

http://www.w3.org/2001/XMLSchema#string

P2860

Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

In vivo demonstration of impaired microcirculation in steatotic human liver grafts.

Atherosclerosis is an inflammatory disease.

Anti-inflammatory and anti-apoptotic roles of endothelial cell STAT3 in alcoholic liver injury

The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough.

Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration.

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis.

Role of endothelial dysfunction in atherosclerosis.

P304

e32785

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0032785

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Jordi Gracia-Sancho

Juan Carlos García-Pagan

Vincenzo La Mura

P577

2012-04-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

222760320

http://www.w3.org/2001/XMLSchema#string

P698

22509248

http://www.w3.org/2001/XMLSchema#string

P921

P932

3317918

http://www.w3.org/2001/XMLSchema#string